← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicstaleAstraZenecaDM1 in Oatp1a/b -/- was 1Phase 2

Cabazitaxel (Cabazitaxel)

Progressive Metastatic Castrate-Resistant Prostate Cancer · FRα

#FR#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 57.7%임상시험 57상태 DISCONTINUED
AntibodystaleWei-Che KoPhase 3

Canakinumab (Canakinumab)

Skin Inflammation; Allergic Contact Dermatitis · Skin Inflammation

#SkinInflammation#Antibody#Phase3#인기#항체+5
효능 ORR 4.9%임상시험 57상태 RECRUITING
AntibodyUCB PharmaPhase 3

CDP870 (Certolizumab Pegol, Certolizumab Pegol (CDP870))

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#인기#항체+3
효능 ORR 5%임상시험 57상태 ACTIVE
ADCBiologicstaleAmerican Society of Clinical On…Phase 2

Dabrafenib plus Trametinib (Dabrafenib plus Trametinib)

Lymphoma, Non-Hodgkin; Multiple Myeloma · Lymphoma, Non-Hodgkin

#LymphomaNon-Hodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
AntibodystalePfizerPhase 3

Elotuzumab (Elotuzumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#인기#항체+4
효능 ORR 100%임상시험 57상태 RECRUITING
CGTBiologicstaleMultan Medical And Dental Colle…Phase 2

Isotretinoin (Isotretinoin)

Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase2#인기#세포유전치료+4
효능 ORR 95.4%임상시험 57상태 DISCONTINUED
CGTBiologicstaleGilead SciencesPreclinical

Ledipasvir-Sofosbuvir (Ledipasvir-Sofosbuvir)

Chronic Hepatitis C (Disorder) · Chronic Hepatitis C

#ChronicHepatitisC#CGT#Preclinical#인기#세포유전치료+5
효능 ORR 1.5%임상시험 57상태 ACTIVE
CGTBiologicstaleImmunityBio, Inc.vedotin (BT8009) and dual-A…Phase 2

IL-15 Superagonist (N-803, N-803 (IL-15 Superagonist))

High-risk Prostate Cancer · High-risk Prostate Cancer

#High-riskProstateCancer#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80%임상시험 57상태 DISCONTINUED
AntibodyRochederuxtecan alone or followe…Phase 3

trastuzumab (Herceptin, Paclitaxel + Trastuzumab)

HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase3#인기#항체+5
효능 ORR 80%임상시험 57상태 RECRUITING
ADCBiologicSeagen Inc.Vedotin for Relapsed or Ref…Phase 2

SGN-35 (SGN-35)

Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic · Disease, Hodgkin

#DiseaseHodgkin#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 93%임상시험 57상태 ACTIVE
ADCBiologicAbbViePhase 3

Steroid eye drops (Steroid eye drops)

Glioblastoma Multiforme · Glioblastoma Multiforme

#GlioblastomaMultiforme#ADC#Phase3#인기#항체약물접합체+3
효능 ORR 6%임상시험 57상태 DISCONTINUED
ADCBiologicstalePfizerderuxtecan and tucatinibPhase 3

Tucatinib (Tucatinib)

Dynamic Tumor Resistance; Metastatic Colorectal Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 100%임상시험 57상태 RECRUITING
ADCBiologicstaleRocheDM1 via butelase-1 with ABD…Phase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1)

Bone Metastases; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 69.7%임상시험 57상태 ACTIVE
CGTBiologicFate Therapeuticsvedotin (BV) or the anti-PD…Phase 1

allogenic NK cells (allogenic NK cells)

Acute Myeloid Leukemia · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase1#인기#세포유전치료+5
효능 0%임상시험 57상태 ACTIVE
CGTBiologicstaleImmunityBio, Inc.Phase 2

ALT-803 (ALT-803)

Melanoma · Acute Myeloid Leukemia

#AcuteMyeloidLeukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 33%임상시험 56상태 DISCONTINUED
ADCBiologicstaleEpizyme, Inc.Phase 2

Abiraterone + prednisone (Abiraterone + prednisone)

Metastatic Prostate Cancer; Metastatic Castration-resistant Prostate Cancer · mCRPC

#mCRPC#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 46%임상시험 56상태 RECRUITING
ADCBiologicAstraZenecaPhase 2

Albumin-paclitaxel + platinum (Albumin-paclitaxel + platinum)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#인기#항체약물접합체+3
효능 ORR 64.3%임상시험 56상태 RECRUITING
CGTBiologicstaleMarzieh EbrahimiPhase 1

Allogenic NK cells infusion (Allogenic NK cells infusion)

Neuroblastoma, Recurrent, Refractory; Neuroblastoma (NB) · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 5%임상시험 56상태 RECRUITING
CGTBiologicstaleMinsk Scientific-Practical Cent…Phase 2

Anti-BCMA CAR-T cells (Anti-BCMA CAR-T cells)

Multiple Myeloma Refractory · BCMA

#BCMA#CGT#Phase2#인기#세포유전치료+5
효능 ORR 97.1%임상시험 56상태 RECRUITING
ADCBiologicSerum Life Science Europe GmbHPhase 2

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression · Non-muscle Invasive Bladder Cancer

#Non-muscleInvasiveBladderCancer#ADC#Phase2#인기#항체약물접합체+4
임상시험 56상태 RECRUITING

19 / 177 페이지

← 이전다음 →